Mauritius, 10 March 2017 – CIDP, Centre International de Développement Pharmaceutique, a Mauritius-based private and independent Contract Research Organisation (CRO), today announces its participation in in-cosmetics Global 2017 from 4 – 6 April in London. At the event, CIDP will share more about its full suite of services with the cosmetics industry, as well as present its innovative study protocol for substantiating anti-pollution claims made on cosmetic products.
CIDP is a pioneer international group that specialises in research and development activities for cosmetics, pharmaceutical, medical device, and nutrition, industries. With more than 15 years of experience, CIDP is a leading company in the field offering extensive scientific expertise in the dermo-cosmetics sector.
“Having served the personal care market for nearly two decades, CIDP is familiar with manufacturers’ research needs and well-versed with the techniques required,” said Mr Jean-Louis Roule, CEO of CIDP. “We’re excited to introduce a new set of standard methodologies to address the rising popularity of anti-pollution claims at in-cosmetics Global this year.”
Asian Utility Week - 5/25/2017
One of the most widely accepted mechanism of action of pollutants on the skin is based on the formation of Reactive Oxygen Species (ROS), and the interaction of these free radicals with biological components. On 4 April at 5:15pm, Mrs Véronique NEWTON, R&D Manager at CIDP, will deliver a presentation on the company’s innovative study protocol for substantiating the anti-pollution claim in an in-cosmetics Global Conference Session held in Theatre 3.
Visitors can also find out more about CIDP’s study protocol and full suite of services – which comprises research activities, in vitro testing, analytical chemistry, formulation, and clinical research – at Booth DD11.
About Centre International de Développement Pharmaceutique (CIDP)
Based in Mauritius, CIDP, Centre International de Développement Pharmaceutique is a private and independent Contract Research Organisation (CRO) that conducts high-performing research and clinical activities for cosmetics, pharmaceutical, medical device, and nutrition industries. The group serves clients both as a service provider upstream through Research and Preclinical activities, and downstream through Regulatory Affairs, Biostatistics & Data Management, and Clinical Research.
Comprising a strong team of highly qualified and experienced professionals, such as doctors, pharmacists, biologists and chemists, clinical research/trial assistants and managers, biostatisticians, and data managers, CIPD’s scientific know-how covers various aspects of drug discovery, and services offered include the evaluation of ingredients, raw materials, as well as drugs or cosmetics products.
The geographical locations of CIDP’s centres – in Mauritius, Brazil, India, Romania and Singapore – enable the company the access to a wide panel of patients. This allows the group to undertake multi-centric trials with a rapid recruitment process in a secured and adapted environment. Recognised for its expertise, CIDP works with the leaders of the cosmetics and pharmaceutical industry.
CIDP forms part of the IBL group. IBL is ranked among the 16 most dynamic and fast growing companies in Africa, according to the World Economic Forum in 2016. Ranked number 1 in the TOP 100 Mauritian companies and number 3 in the Indian Ocean, IBL invests in Life sciences through its subsidiary: IBL Life. Its ambition is to become the essential starting point in this growing sector.
Editorial Contact – please do not publish
Ms Kelly Kuan | t: +65 6220 7573 | e: email@example.com